Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Akebia Therapeutics, Inc. (AKBA)

« Back to company index

AKBA Chatter Timeline

Stock Ticker for AKBA

Most Active Tweeters for AKBA

UserTweets
@Tickeron 11
@BlueBioNow 4
@gcassidy718 4
@ConsumerFeed 3
@TheMarketsDaily 3

Recent Tweets for AKBA

bigpharmaguy @bigpharmaguy
Does anyone think $AKBA vadadustat holds a candle to Roxa? $FGEN
April 9th 2020, 2:04pm
BlueBioNow @BlueBioNow
$AKBA the valuation looks good ?????????????? 3.06 % change recently https://t.co/3l9sowYFvl
April 9th 2020, 12:04am
Tickeron @Tickeron
$AKBA enters a Downtrend because Momentum Indicator dropped below the 0 level on April 7, 2020. View odds for this… https://t.co/SkyBUveT9M
April 8th 2020, 5:04pm
signaljumper @signaljumper
$AKBA at this level still a buy. Should be trading in a few month in double digits
April 8th 2020, 11:04am
ConsumerFeed @ConsumerFeed
Akebia Therapeutics Inc $AKBA Receives $14.75 Consensus Price Target from Brokerages https://t.co/mJTITM2Zi2
April 8th 2020, 8:04am
BlueBioNow @BlueBioNow
$AKBA that looks like an 'I can't believe I gave you so much money and you're blowing it' kinda hand strangle -2.9… https://t.co/Pz1h0QaF1N
April 7th 2020, 8:04pm
Tickeron @Tickeron
$AKBA enters an Uptrend because Momentum Indicator exceeded the 0 level on March 25, 2020. View odds for this and o… https://t.co/3HWpY9Fq7T
April 7th 2020, 5:04pm
Gambiste1 @Gambiste1
RT @farcap: $akba #auryxia provides patients with a life saving treatment in a pill form that they would otherwise have to go to a clinic t…
April 7th 2020, 12:04pm
farcap @farcap
$akba #auryxia provides patients with a life saving treatment in a pill form that they would otherwise have to go t… https://t.co/ESyjzwwl2L
April 7th 2020, 11:04am
marketexclusive @marketexclusive
$AKBA AKEBIA THERAPEUTICS, INC. (NASDAQ:AKBA) Files An 8-K Departure of Directors or Certain Officers; Election of… https://t.co/98L3SgTY8P
April 7th 2020, 10:04am
1MinuteStock @1MinuteStock
Do you know that #WallStreet price for $AKBA is $15.04 https://t.co/QHApvWEHNS
April 7th 2020, 9:04am
1MinuteStock @1MinuteStock
Unicorn Bay rating for $AKBA is 1.81 out of 5. https://t.co/fAcg8NFEGH
April 7th 2020, 9:04am
InsiderAlertsIA @InsiderAlertsIA
$AKBA: New Insider Filing on Akebia Therapeutics, Inc.'s Insider MYLES WOLF: https://t.co/Z2uZUIaUaB
April 7th 2020, 8:04am
otcdynamics @otcdynamics
$AKBA Akebia Therapeutics Appoints Myles Wolf, M.D., https://t.co/6kuwmHoB7t., Chief of Nephrology and Professor at… https://t.co/JFtPVJ3wB5
April 7th 2020, 8:04am
fintel_io @fintel_io
$AKBA / Akebia Therapeutics files form 8-K - Departure of Directors or Certain Officers; Election of Directors; App… https://t.co/L2bIfC6SQR
April 7th 2020, 8:04am
gcassidy718 @gcassidy718
$AKBA My valuations is at $7.81. Waiting for it to come down. https://t.co/WkIGTTkD3C
April 6th 2020, 6:04pm
TheMarketsDaily @TheMarketsDaily
Akebia Therapeutics $AKBA Raised to “Buy” at ValuEngine https://t.co/9jrxLawe2z
April 6th 2020, 2:04am
EnterpriseLeade @EnterpriseLeade
Akebia Therapeutics $AKBA Raised to “Buy” at ValuEngine https://t.co/K8ZSGulStr
April 6th 2020, 2:04am
OlympiaReport @OlympiaReport
Zacks: Analysts Anticipate Akebia Therapeutics Inc $AKBA to Announce -$0.63 Earnings Per Share https://t.co/nvx6HnqAgm
April 6th 2020, 12:04am
OlympiaReport @OlympiaReport
Akebia Therapeutics Inc $AKBA Expected to Post Quarterly Sales of $77.54 Million https://t.co/BkSr2P2A8H
April 6th 2020, 12:04am
gcassidy718 @gcassidy718
$AKBA damn if we pass $6.06 -4.81 % change recently https://t.co/WkIGTTkD3C
April 5th 2020, 9:04pm
HealthcareBeat @HealthcareBeat
Akebia Therapeutics Upgraded to Buy at ValuEngine $AKBA https://t.co/juTWlq6qYw
April 5th 2020, 8:04pm
dispatchtribune @dispatchtribune
Akebia Therapeutics $AKBA Upgraded at ValuEngine https://t.co/wXLZcXrUyI
April 5th 2020, 3:04pm
WeekHerald @WeekHerald
Akebia Therapeutics $AKBA Upgraded at ValuEngine https://t.co/V2oAYHV3Yx
April 5th 2020, 3:04pm
bbnsnews @bbnsnews
Akebia Therapeutics $AKBA Upgraded to Buy at ValuEngine https://t.co/HesrSZ40kR
April 5th 2020, 3:04pm
dispatchtribune @dispatchtribune
ValuEngine Upgrades Akebia Therapeutics $AKBA to Buy https://t.co/nsNwxCRloB
April 5th 2020, 3:04pm
WeekHerald @WeekHerald
ValuEngine Upgrades Akebia Therapeutics $AKBA to Buy https://t.co/b7YD553gnq
April 5th 2020, 2:04pm
stocknewstimes @stocknewstimes
Akebia Therapeutics $AKBA Upgraded to Buy at ValuEngine https://t.co/rppj8imVJW
April 5th 2020, 2:04pm
ConsumerFeed @ConsumerFeed
Akebia Therapeutics $AKBA Upgraded to Buy at ValuEngine https://t.co/vC1dkqs1fl
April 5th 2020, 2:04pm
TranscriptDaily @TranscriptDaily
Akebia Therapeutics $AKBA Upgraded to Buy at ValuEngine https://t.co/mO7xeF9RKw
April 5th 2020, 2:04pm
WatchlistN @WatchlistN
Akebia Therapeutics Inc $AKBA Receives Consensus Rating of “Buy” from Analysts https://t.co/qBQ1oClTTP
April 5th 2020, 6:04am
AmericanBanking @AmericanBanking
Akebia Therapeutics Inc $AKBA Receives Consensus Rating of “Buy” from Analysts https://t.co/pjIPMN8ZjU #stocks
April 5th 2020, 6:04am
BlueBioNow @BlueBioNow
$AKBA "Everything is impossible until someone does it" -4.81 % change recently https://t.co/3l9sowYFvl
April 5th 2020, 5:04am
PakoRuben @PakoRuben
RT @Tickeron: $AKBA in Uptrend: price expected to rise as it breaks its lower Bollinger Band on March 10, 2020. View odds for this and othe…
April 4th 2020, 5:04pm
Tickeron @Tickeron
$AKBA in Uptrend: price expected to rise as it breaks its lower Bollinger Band on March 10, 2020. View odds for thi… https://t.co/BKZZ90xZPm
April 4th 2020, 5:04pm
BlueBioNow @BlueBioNow
$AKBA considerable price movement -2.26 % change recently https://t.co/3l9sowYFvl
April 3rd 2020, 6:04pm
Tickeron @Tickeron
$AKBA enters an Uptrend as Momentum Indicator exceeded the 0 level on March 25, 2020. View odds for this and other… https://t.co/384vf2wQgq
April 3rd 2020, 5:04pm
Tickeron @Tickeron
$AKBA's price moved below its 50-day Moving Average on March 9, 2020. View odds for this and other indicators:… https://t.co/34PdNqhDyr
April 2nd 2020, 5:04pm
otcdynamics @otcdynamics
$AKBA Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/q9YV9c8Glo
April 2nd 2020, 4:04pm
ChartMill @ChartMill
$AKBA was analyzed by 6. The buy percentage consensus is at 90. So analysts seem to be very confident about $AKBA.… https://t.co/mM4dUzsWxP
April 2nd 2020, 12:04am
Tickeron @Tickeron
$AKBA's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators:… https://t.co/pdDSH5X8s5
April 1st 2020, 8:04pm
ChartMill @ChartMill
$AKBA shows a strong growth in EPS: 33.20%. https://t.co/1khnMUlApa https://t.co/xJS29qiJ2w
April 1st 2020, 1:04pm
Gambiste1 @Gambiste1
RT @fda_tracker: $AKBA Phase 2 trial w/est Apr completion date NCT03799627: https://t.co/FAciCygTD2 Trial Tracker: https://t.co/aR7q5oJwjn
April 1st 2020, 9:04am
fda_tracker @fda_tracker
$AKBA Phase 2 trial w/est Apr completion date NCT03799627: https://t.co/FAciCygTD2 Trial Tracker: https://t.co/aR7q5oJwjn
April 1st 2020, 9:04am
TheMarketsDaily @TheMarketsDaily
-$0.45 EPS Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/GNZSKGee9q
April 1st 2020, 6:04am
dakotafinancial @dakotafinancial
-$0.45 EPS Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/N5VU62rXb3
April 1st 2020, 6:04am
Tickeron @Tickeron
$AKBA's Aroon indicator reaches into Uptrend on March 27, 2020. View odds for this and other indicators:… https://t.co/7XDvgEcxj4
March 31st 2020, 5:03pm
AmericanBanking @AmericanBanking
$77.54 Million in Sales Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/U68QHpamY2 #stocks
March 31st 2020, 4:03am
WatchlistN @WatchlistN
$77.54 Million in Sales Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/KFN1LDSAQ4
March 31st 2020, 4:03am
ThisLincolnian @ThisLincolnian
$77.54 Million in Sales Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/xXgigVbQ83
March 31st 2020, 4:03am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2020. All rights reserved.